Source:http://linkedlifedata.com/resource/pubmed/id/11237842
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2001-3-12
|
| pubmed:abstractText |
Little is known about the epidemiology of human herpesvirus 8 (HHV-8) infections among women. A cross-sectional study was conducted of HHV-8 infection among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. Serological tests with noninduced (latent) and induced (lytic) HHV-8 antigens were used to detect infection among 2483 participants of a multisite cohort. Reactivity to latent antigen was present in 4.1% and to induced antigens in 12.0% of women. Seven of 8 women who reported Kaposi's sarcoma had HHV-8 antibodies. Among HIV-positive women, HHV-8 infection was associated with use of crack, cocaine, or heroin (76% vs. 65%; P<.001), past syphilis (29% vs. 20%; P<.001), an injection drug-using male sex partner (61% vs. 53%; P=.014), black race (P=.010), and enrollment site (P=.015). In multivariate analysis, HIV infection, older age, past syphilis, black race, and enrollment site were independently associated with HHV-8 infection. In this cohort of North American women, HHV-8 infection was associated with HIV infection, drug use, and risky sexual behavior.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0022-1899
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
183
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1130-4
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:11237842-Adult,
pubmed-meshheading:11237842-Antibodies, Viral,
pubmed-meshheading:11237842-California,
pubmed-meshheading:11237842-Cocaine,
pubmed-meshheading:11237842-Cohort Studies,
pubmed-meshheading:11237842-Crack Cocaine,
pubmed-meshheading:11237842-Cross-Sectional Studies,
pubmed-meshheading:11237842-District of Columbia,
pubmed-meshheading:11237842-Female,
pubmed-meshheading:11237842-HIV Infections,
pubmed-meshheading:11237842-HIV Seronegativity,
pubmed-meshheading:11237842-HIV Seropositivity,
pubmed-meshheading:11237842-Heroin,
pubmed-meshheading:11237842-Herpesviridae Infections,
pubmed-meshheading:11237842-Herpesvirus 8, Human,
pubmed-meshheading:11237842-Humans,
pubmed-meshheading:11237842-New York,
pubmed-meshheading:11237842-Prevalence,
pubmed-meshheading:11237842-Risk Factors,
pubmed-meshheading:11237842-Sarcoma, Kaposi,
pubmed-meshheading:11237842-Seroepidemiologic Studies,
pubmed-meshheading:11237842-Sex Factors,
pubmed-meshheading:11237842-Substance Abuse, Intravenous,
pubmed-meshheading:11237842-Syphilis
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
|
| pubmed:affiliation |
University of California, San Francisco, Infectious Diseases Division, San Francisco, CA 94122, USA. ruthg@itsa.ucsf.edu
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|